-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Posaconazole in Fungal Infections
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Posaconazole in Fungal Infections report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Posaconazole in Fungal Infections Drug Details: Posaconazole (Noxafil, Posanol, Posaconazole SP,...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Posaconazole in Neutropenia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Posaconazole in Neutropenia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Posaconazole in Neutropenia Drug Details:Posaconazole (Noxafil, Posanol, Posaconazole SP, Spriafil) is a triazole antifungal...
-
Company Profile
Banca IFIS SpA – Company Profile
Banca IFIS SpA (Banca IFIS) a subsidiary of La Scogliera S.p.A., is a financial services provider. It offers current and savings accounts; mortgage, personal, and corporate loans; and credit cards. It offers import and export, recourse, non-recourse, maturity, and indirect factoring, among others; leasing for vehicle and capital goods; rental services for IT and office equipment, industrial machinery, and health care sector. Its corporate finance includes structured finance, medium-long term loans, and subsidized loans. Its other services include debt financing...
Add to Basket -
Product Insights
Net Present Value Model: Noxafil
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model Noxafil Drug Details Posaconazole (Noxafil, Posanol,...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – posaconazole
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry posaconazole Drug Details Posaconazole (Noxafil, Posanol, Posaconazole SP, Spriafil) is a triazole antifungal drug....